LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to extend life in tough esophageal cancer
Disease control Recruiting nowThis study tests a shorter course of chemotherapy and radiation combined with the immunotherapy drug camrelizumab for people with advanced esophageal cancer that cannot be removed by surgery. About 98 participants will receive either the combo therapy followed by maintenance immu…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Ning Jiang, M.D./Ph.D. • Aim: Disease control
Last updated May 26, 2026 10:21 UTC
-
Nutrition boost may help fight esophageal cancer
Disease control Recruiting nowThis study tests whether intensive nutritional support can improve outcomes for people with locally advanced esophageal cancer that cannot be surgically removed yet. Participants receive standard chemotherapy plus immunotherapy, and are randomly assigned to either intensive nutri…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated May 26, 2026 10:10 UTC
-
New pill combo offers hope for Hard-to-Treat esophageal cancer
Disease control Recruiting nowThis study tests a chemotherapy pill (oral paclitaxel) combined with radiation for people with advanced esophageal cancer that cannot be removed by surgery. It is for patients aged 70 or older or those who cannot tolerate standard IV chemo. The goal is to see if this approach is …
Matched conditions: LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated May 26, 2026 10:05 UTC